U.S. Biotech Stock News

Earlier in March, Campbell's reported fiscal Q2 2026 results showing lower net sales and EBIT, as storms in January disrupted shipments and lifted supply chain costs. These results come amid two years of falling unit sales and a projected 2.6% sales decline over the next 12 months, underscoring demand pressure in Campbell's core categories. Next, we’ll examine how weaker demand and weather-related supply chain disruptions might reshape Campbell's previously outlined investment...

Wondering whether WD-40 at around US$201 a share looks expensive, cheap, or somewhere in between? This article breaks down what the current price really represents. The stock is up 2.3% year to date, but that sits alongside a 5.9% decline over the last week, an 18.1% decline over the last month, and a 15.3% decline over the last year, which can change how investors think about both opportunity and risk. Recent coverage has focused on WD-40 as a long established brand in household products,...

Insiders who bought AstroNova, Inc. ( NASDAQ:ALOT ) stock in the last 12 months were richly rewarded last week. The...

How Garrett Motion has been trading Garrett Motion (GTX) has recently seen mixed share performance, with a 3.2% decline in the last session, a 4.7% gain over the past week, and a 12.5% decline over the past month. See our latest analysis for Garrett Motion. At a share price of $17.76, Garrett Motion has recently seen short term share price gains cool after a 30 day share price return decline of 12.5%, but its 1 year total shareholder return of 121.3% points to a much stronger longer term...

On March 23, 2026, Piper Sandler Companies filed an amendment to its Delaware certificate of incorporation to complete a four-for-one forward stock split of its common stock, maintain the par value at US$0.01, increase authorized shares from 100,000,000 to 400,000,000, and begin split-adjusted trading on March 24 under a new CUSIP. This move materially increases the share count and lowers the price per share, which can broaden investor accessibility and enhance trading liquidity without...

Wondering whether McKesson at around US$860 a share still offers value or is pricing in most of its strengths already? This breakdown will help you frame that question clearly. The stock has seen a 2.9% decline over the last week and a 10.7% decline over the last month, although it still sits on a 4.5% return year to date and a 29.3% return over the past year. Recent coverage has focused on McKesson's role across healthcare distribution and services, as investors weigh how sector wide trends...

Columbia Sportswear stock in focus Columbia Sportswear (COLM) is back on investors’ radar after recent share price weakness, with the stock showing negative returns over the past month, past 3 months, year to date, and over the past year. See our latest analysis for Columbia Sportswear. With the share price at $54.61 and a 30 day share price return of 10.27% decline, alongside a 1 year total shareholder return of 25.91% decline, recent weakness points to fading momentum and ongoing pressure...

Millrose Properties (NYSE:MRP) has amended its credit facility, expanding it into a larger unsecured structure. The company is transitioning from a secured facility to an unsecured framework with added term loan capacity. This shift represents a material change in Millrose's capital structure and liquidity profile. For a real estate focused business like Millrose Properties, access to flexible credit can be just as important as the properties it owns. The move toward an unsecured facility...

Recent share price performance and business snapshot Copart (CPRT) has stayed in focus after a weak run in the shares, with the stock showing negative returns over the past week, month, past 3 months, year to date, and past year. At a recent close of US$32.43, Copart operates online auctions and vehicle remarketing services across the United States and multiple international markets, generating US$4.6b in revenue and US$1.6b in net income. See our latest analysis for Copart. The recent 30 day...

MSCI (MSCI) has been drawing attention after a period of weaker share performance, with the stock showing negative returns over the past month and past 3 months despite sizeable revenue and net income levels. See our latest analysis for MSCI. The recent weakness, including a 1 day share price return of 2.11% and a 90 day share price return of 10.53%, contrasts with a 5 year total shareholder return of 28.84%. This indicates that momentum has been fading after a longer period of value...

ASGN stock reaction and recent performance ASGN (ASGN) has drawn attention after recent share price moves, with the stock closing at $37.56 and showing mixed returns over the past week, month, and past 3 months. See our latest analysis for ASGN. That 5.9% one day share price decline sits within a wider losing stretch, with a 30 day share price return of 8.5% and a 90 day share price return of 24.9%. At the same time, the 1 year total shareholder return of 40.4% and 5 year total shareholder...

JFrog (FROG) is back in focus after UBS upgraded the stock, pointing to the company’s rapid handling of a recent supply chain attack and its new AI security offerings, including the JFrog MCP Registry. See our latest analysis for JFrog. Despite the upgrade-driven jump, JFrog’s recent share price performance has been mixed, with an 11.8% 1 month share price return contrasted against a 35.25% 3 month share price decline. Its 1 year total shareholder return of 35.42% suggests momentum over a...

Palantir Technologies stock snapshot: recent moves and business context Palantir Technologies (PLTR) has drawn attention after recent trading, with the share price at $143.06 and mixed short term returns, including a 3.0% decline over the past day and a 5.1% decline over the past week. Over the past month, the stock shows a 6.6% gain. The past 3 months reflect a 24.2% decline, alongside a 14.8% decline year to date. Over the past year, total return stands at 66.6%. See our latest analysis for...

Phibro Animal Health (PAHC) has drawn investor attention after recent share price swings, including a 3.5% decline over the past day, in contrast to positive moves over the past week and the past three months. See our latest analysis for Phibro Animal Health. At a share price of US$53.88, Phibro Animal Health has seen short term volatility, with a 3.5% one day share price decline sitting alongside recent momentum that includes a 41.2% 90 day share price return and a 1 year total shareholder...

Apple plans to open Siri to third party AI assistants like Gemini and Claude, ending the current ChatGPT exclusivity. The change is intended to turn Siri into a universal entry point for multiple AI models across Apple devices. Apple also aims to route and monetize AI service subscriptions through the App Store as part of this move. For investors watching NasdaqGS:AAPL, the news comes with the stock trading around $248.8 and long term returns that remain substantial, up 53.1% over 3 years...

Why FactSet Research Systems (FDS) is on investors’ radar FactSet Research Systems (FDS) has drawn fresh attention after a period of pressure on the share price, with the stock showing negative returns over the past year and past 3 months. That pullback is prompting some investors to revisit the company’s fundamentals, including its US$2,360.7m in revenue, US$599.6m in net income, and global footprint across the Americas, EMEA, and Asia Pacific. See our latest analysis for FactSet Research...

Geopolitical disruption in the Middle East has pushed global buyers toward U.S. LNG, putting Cheniere Energy (LNG) in focus as the largest American exporter, especially after the first LNG production from CCL Stage 3 Train 5. See our latest analysis for Cheniere Energy. The recent 34.54% 1 month share price return, together with a 56.84% 3 month share price return and 32.5% 1 year total shareholder return, indicates that momentum has been strengthening as investors reassess Cheniere's growth...

In recent weeks, Delta Air Lines has benefited from easing oil prices, resilient premium travel demand and early signs of relief from U.S. airport disruptions as lawmakers move to end the government shutdown. Together, lower fuel cost pressures, stronger high-end bookings and the prospect of smoother airport operations highlight how both commodity markets and Washington politics can quickly reshape the airline’s operating backdrop. Next, we’ll examine how resilient premium demand in...

Recent disruptions to shipping through the Strait of Hormuz have tightened global fertilizer supply, pushing up prices and boosting prospects for nitrogen-focused producers such as CVR Partners. Analysts at Bank of America have highlighted that these elevated earnings for fertilizer makers may be short-lived, as industry conditions typically cycle back toward more normal levels once geopolitical tensions ease. We’ll now consider how the prospect of short-term windfall profits from tighter...

If you are wondering whether Merchants Bancorp at around US$42.27 is still offering value or edging toward the expensive side, you are not alone. The stock has returned 2.6% over the last week, 27.4% year to date and 15.4% over the past year, with a 2.4% decline across the last 30 days adding a bit of extra uncertainty for anyone thinking about entry points. Recent attention around Merchants Bancorp has centered on its position in the diversified financials space and how investors are...

Event context and recent performance Saul Centers (BFS) has attracted fresh attention after recent share price moves. The stock closed at $32.34, with a 1-day return of a 1% decline, a flat performance over the week, and a 5.8% decline over the past month. See our latest analysis for Saul Centers. That recent 5.8% one month share price decline sits against a modest 2.5% 90 day share price return and a 2.5% year to date share price gain. The 1 year total shareholder return is slightly...

What recent performance says about Tapestry (TPR) Tapestry (TPR) has seen its share price slip about 1.8% over the past day and roughly 1.4% over the past week, while the stock is down around 11.5% over the past month. Despite these shorter term declines, Tapestry shows a positive return of about 5.7% over the past 3 months and 7.6% year to date, with a 1 year total return near 100.5%. See our latest analysis for Tapestry. Recent trading has cooled after a strong run, with the latest share...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Steel...

Why ArriVent BioPharma (AVBP) is on investors’ radar ArriVent BioPharma (AVBP) has drawn attention after recent trading, with the stock last closing at US$21.43 and showing mixed short term performance across the past week, month, and past 3 months. See our latest analysis for ArriVent BioPharma. At the current share price of US$21.43, ArriVent BioPharma’s recent 30 day share price return of a 7.99% decline contrasts with a 3.03% year to date share price gain and a 13.09% total shareholder...